Despite the fact that the federal government has not approved requests to waive a number regulations that would thwart it, Kansas is moving ahead with its KanCare Medicaid overhaul
Despite the fact that the federal government has not approved requests to waive a number regulations that would thwart it, Kansas is moving ahead with its KanCare Medicaid overhaul.
According to the Associated Press (AP), Gov. Sam Brownback plans to turn Medicaid over to three private, managed-care companies starting Jan. 1 after awarding contracts this summer.
But because the federal government provides a majority of the funding for the state's $2.9 billion-a-year program, it must approve multiple waivers Kansas has requested. The state administration is confident the waivers will be approved because the federal government has approved them for other states. Kansas expects approval in August, but AP quotes a federal spokesman who says there is no formal timetable for making a decision.
Kansas submitted its requests a day before new rules for waiver applications took effect. The new rules require two public hearings, public notifications and a report on public comments before submitting an application.
Go back to the Managed Healthcare Executive eNews newsletter.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More